Having endured months of uncertainty in the wake of protracted legal wrangling over government’s initial proposals on dispensing fees, introduced in April 2004, pharmacists say they are uneasy about the latest model unveiled by the health department on Thursday.
Public-Private Mix
New pricing model has pharmacists worried
Business Day (Johannesburg), 11 March 2006
Uganda: Companies scale-up Aids campaigns
Mukombozi R, The Monitor (Kampala), 21 March 2006
Through the theme: "Saving lives, Saving money," Ugandan businesses are being sponsored with modules designed to prevent the spread of HIV/Aids through training programmes and awareness campaigns on better access to ARVs. This presents a detailed argument for the care of employees with HIV/AIDS.
Public-private partnerships. Partnerships for public health
Multi Stakeholder Processes
Public-private partnerships are becoming a popular mode of tackling large, complicated, and expensive public health problems. The idea of partnerships for public health has emerged in national and international policy discussions, in both rich and poor countries. Yet we are still learning about how best to manage these new partnerships, as is discussed in this book.
Private sector options to increase access to medicines for child health
This report, from Rational Pharmaceutical Management (RPM) Plus, examines a number of innovative field interventions to increase access to medicines for child health through the private sector in Tanzania. The first part of the report details a number of programmes and interventions that are currently in operation in Tanzania. These include projects on: shopkeeper interventions; low-interest loans to Accredited Drug Dispensing Outlets (ADDOs); voucher schemes; and microfinance schemes.
Global Public Goods for Health
Smith R., Beaglehole R., Woodward D., Drager N. (ed.) Global Public Goods for Health: health economics and public health perspectives. Oxford, Oxford University Press, 2003. 320 p.
Global Public Goods for Health addresses the growing globalization of health from the unique perspective of the economic concept of public goods. This concept identifies where a ‘good’ or service (such as knowledge of an infectious disease outbreak) which would be of benefit globally will not be produced or disseminated if left to ‘the market’, because of a lack of incentive: no-one can be excluded from accessing the good, no charge can be levied for use and no costs recouped.
Measuring the public-health potential of new treatments for malaria in Africa
Poverty is a major factor in the continuing burden of malaria in sub-Saharan Africa. The gross national product (GNP) per capita is around US$306, or less than $1 per day. On average, these countries spend less than $20 per head of population per year on health care. Patients urgently need new therapies to combat malaria. However, malaria is not an economically viable disease for drug developers and new antimalarials are therefore usually developed within public–private partnerships.
Public health approach is key to scaling up HIV treatment, says WHO HIV/AIDS director
Speaking in December at the 14th International Conference on HIV/AIDS and Sexually Transmitted Infections in Africa (ICASA), in Abuja, Nigeria, Jim Yong Kim, Director of the World Health Organization (WHO) HIV/AIDS Department, emphasized the importance of a public health approach in promoting long-term sustainability and equity of HIV treatment access programmes in resource-limited settings.
Medical costs push millions of people into poverty across the globe
Each year 100 million people slide into poverty as a result of medical care payments. Another 150 million people are forced to spend nearly half their incomes on medical expenses. That is because in many countries people have no access to social health protection - affordable health insurance or government-funded health services. Paradoxically, people in the world’s poorest countries contribute relatively more for health care than those in wealthy industrialized nations. In Germany, for example, where the average GDP per capita is US$ 32 860 and almost everyone has social health protection, 10% of all medical expenses nationwide are borne by households.
Public health care under pressure in sub-Saharan Africa
Health Policy. 2005
Taking as point of departure the need for a strong public health care sector in developing countries the article firstly outlines how in sub-Saharan Africa enhanced scarcity has characterized the content and quality of health care in the public sector. This has eroded the trust among the public in the government as provider of health care and guardian of public health. Secondly, it describes how workers in the public health domain have dealt with the implications of scarcity by etching out a "puvate" zone in health care provision and how these informal activities need to be interpreted as "muddling through".
Public-private mix for DOTS: towards scaling up
This report from the World Health Organization summarises proceedings from an international working group meeting on public-private sector mix (PPM) programmes for expanding DOTS (directly observed treatment, short-course), the internationally recognised TB control strategy. The meeting stressed that effective scale-up of PPM DOTS must ensure access to TB care for all population groups. Key barriers to scaling up PPM DOTS included lack of capacity for technical support at national, regional and global levels, and weak advocacy and promotion.